Drug factory · FDA FEI 2245314

Catalent Pharma Solutions

Allendale, New Jersey, United States

Matched to FDA's records by company name, because this plant's registration on the label has expired.

United States: 1

No problems found at FDA's last inspection, Oct 4, 2011.

No Action Indicated: inspectors found no objectionable conditions.

1 drug inspection on record since 2011: 1 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
CalcitriolMakes it Caraco Pharmaceutical Laboratories, Ltd. 63304-239, 63304-240, 63304-241
EstradiolMakes it and tests it Mayne Pharma LLC 50261-104, 50261-110
NifedipineMakes it Leading Pharma, LLC 69315-211, 69315-212
TipranavirMakes it Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0003
Valproic AcidMakes it and tests it Upsher-Smith Laboratories, Inc. 0832-0310

FDA inspection history

EndedResultProgramProblems noted
Oct 4, 2011No problems foundDrug Quality Assurance—